Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Barakaldo – page 11

201 clinical trials in Barakaldo, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Barakaldo at a glance
201
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

201 trials in Barakaldo

Open in trial search
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Astrazeneca Farmaceutica Spain S.A.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Raxtozinameran
  • Sponsor:Hipra Scientific S.L.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Celgene Corp.

Parkinson's disease

Not recruiting
Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:1-[2-[4-(2,4-DIFLUOROPHENOXY)PIPERIDIN-1-YL]-3-[[(3R)-OXOLAN-3-YL]AMINO]-7,8-DIHYDRO-5H-PYRIDO[3,4-B]PYRAZIN-6-YL]ETHANONE
  • Sponsor:Cerevance Beta Inc.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:AstraZeneca AB
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Potassium Chloride
  • Sponsor:Pontificia Universidad Catolica de Chile

Multiple sclerosis

Not recruiting
Investigational
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Frexalimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Pfizer Inc.
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Apadamtase Alfa
  • Sponsor:Baxalta Innovations GmbH

Parkinson's disease

Not recruiting
Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Prasinezumab
  • Sponsor:F. Hoffmann-La Roche AG
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Ofatumumab
  • Sponsor:Novartis Pharma AG

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Barakaldo

What the registry says about research in the country

01 Neurological Disorders

Innovative research focusing on acute cerebral ischemic stroke treatments and groundbreaking studies in Parkinson's disease management, including trials of novel compounds like NEU-411 and CVN424.

  • Stroke intervention studies
  • Early Parkinson's treatments
  • Neurological therapeutics

These trials aim to improve patient outcomes and develop more effective treatment strategies.

02 Oncology Research

Comprehensive cancer studies including treatments for metastatic prostate cancer, pancreatic adenocarcinoma, and innovative approaches in breast cancer therapy.

  • Prostate cancer treatments
  • Hepatic tumors
  • Breast cancer therapies

Focus on developing targeted therapies and improving survival rates across various cancer types.

03 Infectious Diseases

Studies addressing COVID-19 vaccination strategies and treatments for invasive candidiasis, with particular attention to antimicrobial therapies.

  • COVID-19 boosters
  • Fungal infections
  • Endocarditis treatments

These trials evaluate new therapeutic approaches and vaccine effectiveness.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.